[Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Italy]. FE [Internet]. 2022 Jun. 22 [cited 2025 Oct. 29];23(1). Available from: https://journals.seedstm.com/index.php/FE/article/view/1527